Glucose-6-phosphate dehydrogenase deficiency | Ribose-5-phosphate isomerase deficiency | Phosphorus deficiency | Nitrogen deficiency | Lipoprotein lipase deficiency | Iron deficiency (medicine) | Iron deficiency | Holocarboxylase synthetase deficiency | Growth hormone deficiency |
In vivo hemolysis can be caused by a large number of medical conditions, including many Gram-positive bacteria (e.g., Streptococcus, Enterococcus, and Staphylococcus), some parasites (e.g., Plasmodium), some autoimmune disorders (e.g., drug-induced hemolytic anemia), some genetic disorders (e.g., Sickle-cell disease or G6PD deficiency), or blood with too low a solute concentration (hypotonic to cells).
Large doses of menadione have been reported to cause adverse outcomes including hemolytic anemia due to G6PD deficiency, neonatal brain or liver damage, or neonatal death in some rare cases.